THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth announced today that it has received CLIA certification for its clinical lab in the Houston metro area. Under this certification, the lab will offer two tests: a targeted gene panel of more than 500 known cancer genes, and whole exome sequencing of the tumor genome. These tests are an important part of the company’s end-to-end service, which walks patients and their healthcare providers through the molecular diagnostic process—collecting tumor samples, analyzing the samples, and interpreting the results using a unique analytics platform—all to generate safer and more targeted cancer treatment choices.
Help employers find you! Check out all the jobs and post your resume.
